Apotheek Daenen
ActiveSummary
Apotheek Daenen has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €359,126 and a net result of €66,735, of which €74,250 non-recurring income. Equity has been growing by about 4% per year since 2019. Its solvency ranks better than 58% of 5,036 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
Source: KBO- Status
- Active since 31-12-1997 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.086.277.582 3110 Rotselaar, since 08-04-1998
- Financial year end
- 31 December
- Peppol
- Reachable since 18-11-2025
Board and ownership
- PharmaSciManaging director · permanent representative DAENEN Kristien
- PharmaSci100%· score 832025 annual accounts of PharmaSci
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Gross margin
- €261,168
- ▲ 27.6%
- Turnover
- ≈ €950,000
- estimated
- Profit
- €66,735
- Equity
- €359,126
- ▲ 22.8%
- Total assets
- €822,691
- ▲ 3.4%
- Employees on 31-12-2025
- 2
- =
- 2025 accounts filed 21 days after the deadline
Score breakdownraises riskLiquidity: current ratio 1.77, cash €5,986Sector: Retail trade (NACE 47)lowers riskFounded in 1997Size: 1.8 FTE, total assets €822,691Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 58% of them on solvency, 20% on liquidity, 54% on profitability and 75% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 6 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Back in profit in 2025after a loss of €112,260 in 2024 €66,735 View
Recent changes
- · Gazette deed Resignation: DAENEN Erik (director)Reappointment: PHARMASCI (director and managing director) · Permanent representative: DAENEN Kristien
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Apotheek Daenen: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €698,000 and €914,000, founded between 1996 and 2004.
| Company | Total assets | Gross margin |
|---|---|---|
| Apotheek Daenen Rotselaar | €822,691 | €261,168 |
| NB PHARMA Nieuwpoort | €745,538 | €272,272 |
| D'HUYVETTER - VANDERMARLIERE Zulte | €737,810 | €244,606 |
| STEKENE PHARMA Stekene | €898,762 | €265,664 |
| APOTHEEK DECLERCK Kortrijk | €790,903 | €278,652 |
| APOTHEEK OPWIJK LENAERTS Opwijk | €697,583 | €273,194 |
| PHARMACIE WILS APOTHEEK Kraainem | €913,501 | €243,470 |
Key facts about Apotheek Daenen
- What is the company number of Apotheek Daenen?
- The company number of Apotheek Daenen is 0462.332.187. The VAT number is the same number with BE in front: BE 0462.332.187.
- Where is Apotheek Daenen based?
- The registered office is at Stationsstraat 19, 3110 Rotselaar.Company details
- What does Apotheek Daenen do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Apotheek Daenen?
- The legal form of Apotheek Daenen is Public limited company (NV).
- When was Apotheek Daenen founded?
- Apotheek Daenen was founded on 31-12-1997.
- Is Apotheek Daenen still active?
- Yes, Apotheek Daenen is an active enterprise in the KBO register.
- How many employees does Apotheek Daenen have?
- Apotheek Daenen had an average of 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does Apotheek Daenen fall under?
- In its 2025 annual accounts, Apotheek Daenen states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of Apotheek Daenen?
- The turnover in financial year 2025 is ≈ €950,000. This figure is estimated from the gross margin of €261,168 and 47 comparable companies (NACE 477). It probably lies between €740,000 and €1.6m.
- Is Apotheek Daenen profitable?
- In financial year 2025, Apotheek Daenen made a profit of €66,735.
- Where can I find the annual accounts of Apotheek Daenen?
- Apotheek Daenen filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Apotheek Daenen due?
- Apotheek Daenen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.